Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

This study has been completed.
Information provided by:
Roswell Park Cancer Institute Identifier:
First received: April 7, 2003
Last updated: March 7, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Primary Completion Date: May 2003 (Final data collection date for primary outcome measure)
Ramnath N, Sommers E, Anderson T, et al.: Neoadjuvant gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC). [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-2818, 2003.